SARS-CoV-2 Infection Inducing Immune Thrombocytopenic Purpura: Case Series

Abstract

<b>Background:</b> Immune thrombocytopenic purpura (ITP) refers to immune-mediated destruction of platelets. Viral infections have been proposed as an etiology of ITP; antibodies developed in response to infection may cross-react with normal platelets and result in their destruction. <b>Case Series:</b> We report 2 cases in which coronavirus disease 2019 (COVID-19) likely induced severe ITP. <b>Conclusion:</b> ITP may also play a role in the thrombocytopenia observed in some patients with COVID-19. ITP in this patient population may be more prevalent than currently documented.